Početna › Ateroskleroza › Tennessee
Kliničke studije za Ateroskleroza u državi Tennessee
9 studija za Ateroskleroza traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Vanderbilt University School of Medicine (VUSM) - Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Nashville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- WR-Clinsearch, LLC, Chattanooga
- Erlanger Health System, Chattanooga
- The Jackson Clinic, Jackson
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07157774Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE
- St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07594392Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Stern Cardiovascular Foundation Inc, Germantown
- Accellacare of Knoxville, Knoxville
- Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell
- i još 1
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- i još 2
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Chattanooga
- Research Site, Chattanooga
- Research Site, Greeneville
- i još 9
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Novartis Investigative Site, Tullahoma
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06813911Pelacarsen Roll-over Extension Program
- Apex Cardiology Research Associates of Jackson, Jackson
U tijeku regrutacijaFaza 3
Od 18 do 100 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 17. pro 2025. · NCT02915198Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.